Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2003 2
2004 2
2005 2
2006 3
2007 2
2008 4
2009 3
2010 3
2011 6
2012 7
2013 10
2014 7
2015 10
2016 11
2017 4
2018 8
2019 3
2020 2
2021 7
2022 3
2023 1
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

90 results

Results by year

Filters applied: . Clear all
Page 1
[Therapeutic drug monitoring].
Le Guellec C, Bentué-Ferrer D; groupe STP de la SFPT. Le Guellec C, et al. Therapie. 2010 Jan-Feb;65(1):13-5. Therapie. 2010. PMID: 20443240 French. No abstract available.
Niveau de preuve du suivi thérapeutique pharmacologique de l'efavirenz.
Solas C, Gagnieu MC; pour le groupe Suivi Thérapeutique Pharmacologique de la Société Française de Pharmacologie et de Thérapeutique. Solas C, et al. Among authors: gagnieu mc. Therapie. 2011 May-Jun;66(3):197-205. doi: 10.2515/therapie/2011033. Therapie. 2011. PMID: 27393199 French.
Concerns about pharmacokinetic (PK) and pharmacokinetic-pharmacodynamic (PK-PD) studies in the new therapeutic area of COVID-19 infection.
Venisse N, Peytavin G, Bouchet S, Gagnieu MC, Garraffo R, Guilhaumou R, Solas C; ANRS-AC43 Clinical Pharmacology Committee, SFPT Therapeutic Drug Monitoring and Treatment Personalization group. Venisse N, et al. Among authors: gagnieu mc. Antiviral Res. 2020 Sep;181:104866. doi: 10.1016/j.antiviral.2020.104866. Epub 2020 Jul 10. Antiviral Res. 2020. PMID: 32659293 Free PMC article. Review.
[Interest of UGT1A1 genotyping within digestive cancers treatment by irinotecan].
Boyer JC, Etienne-Grimaldi MC, Thomas F, Quaranta S, Picard N, Loriot MA, Poncet D, Gagnieu MC, Ged C, Broly F, Le Morvan V, Bouquié R, Gaub MP, Philibert L, Ghiringhelli F, Le Guellec C. Boyer JC, et al. Among authors: gagnieu mc. Bull Cancer. 2014 Jun;101(6):533-53. doi: 10.1684/bdc.2014.1933. Bull Cancer. 2014. PMID: 24977443 Review. French.
Metallosis-associated prosthetic joint infection.
Barba T, Wach J, Lustig S, Laurent F, Devouassoux-Shisheboran M, Valour F, Chidiac C, Ferry T; Lyon BJI Study Group. Barba T, et al. Med Mal Infect. 2015 Nov-Dec;45(11-12):484-7. doi: 10.1016/j.medmal.2015.09.009. Epub 2015 Nov 14. Med Mal Infect. 2015. PMID: 26584840 No abstract available.
[Evidence-based therapeutic drug monitoring for efavirenz].
Solas C, Gagnieu MC; roupe Suivi Therapeutique Pharmacologique de la Societe Francaise de Pharmacologie et de Therapeutique. Solas C, et al. Among authors: gagnieu mc. Therapie. 2011 May-Jun;66(3):197-205. doi: 10.2515/therapie/2011033. Epub 2011 Aug 9. Therapie. 2011. PMID: 21819803 Review. French.
Therapeutic drug monitoring and virological response at week 48 in a cohort of HIV-1-infected patients switching to dolutegravir/rilpivirine dual maintenance therapy (ANRS-MIE-BIRIDER study).
Lemaitre F, Lagoutte-Renosi J, Gagnieu MC, Parant F, Venisse N, Grégoire M, Bouchet S, Garraffo R, Lê MP, Muret P, Comets E, Solas C, Peytavin G; ANRS-MIE-BIRIDER Study group on behalf of the Clinical Pharmacology Group of ANRS-MIE AC43. Lemaitre F, et al. Among authors: gagnieu mc. Br J Clin Pharmacol. 2024 Jan;90(1):264-273. doi: 10.1111/bcp.15890. Epub 2023 Sep 18. Br J Clin Pharmacol. 2024. PMID: 37602480 Free article.
Ribavirin therapeutic drug monitoring: why, when and how?
Stanke-Labesque F, Loustaud-Ratti V, Babany G, Gagnieu MC, Marquet P; French Ribavirin Group OPTIRIB. Stanke-Labesque F, et al. Among authors: gagnieu mc. Fundam Clin Pharmacol. 2010 Aug;24(4):401-6. doi: 10.1111/j.1472-8206.2009.00778.x. Epub 2009 Sep 24. Fundam Clin Pharmacol. 2010. PMID: 19788564 Review.
Pharmacological exposure to ribavirin: a key player in the complex network of factors implicated in virological response and anaemia in hepatitis C treatment.
Loustaud-Ratti V, Carrier P, Rousseau A, Maynard M, Babany G, Alain S, Trépo C, De Ledinghen V, Bourlière M, Pol S, Di Martino V, Zarski JP, Pinta A, Sautereau D, Marquet P; OPTIRIB group. Loustaud-Ratti V, et al. Dig Liver Dis. 2011 Nov;43(11):850-5. doi: 10.1016/j.dld.2011.04.002. Epub 2011 May 18. Dig Liver Dis. 2011. PMID: 21596633 Review.
90 results